With the analysis among 2,767 patents, we discovered top 347 key players by total patent application. Sarepta Therapeutics, Inc., BioMarin Technologies BV, Merck & Co., Inc. are dominant in this area. They take 19.05% of the total patent filing.
Sarepta Therapeutics, Inc.
Massachusetts, United States
Patent: 371
Noord-Holland, Netherlands
Patent: 79
New Jersey, United States
Patent: 77
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 73
Ohio, United States
Patent: 70
Graffinity Pharmaceuticals AG
Basel-Stadt, Switzerland
Patent: 53
Nippon Shinyaku Co., Ltd.
Kyoto-fu, Japan
Patent: 50
New York, United States
Patent: 39
New Jersey, United States
Patent: 39
With the analysis among 132 patents, we discovered top 17 start-ups by total patent application. Modalis Therapeutics Corp., Institut National de la Santé et de la Recherche Médicale, Mitochon Pharmaceuticals, Inc. are active in this area.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 36
Institut National de la Santé et de la Recherche Médicale
Mitochon Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 14
Basel-Landschaft, Switzerland
Patent: 12
Bretagne, France
Patent: 10
California, United States
Patent: 7
Carrick Therapeutics Ltd.
California, United States
Patent: 4
Dystrogen Therapeutics Corp.
Illinois, United States
Patent: 2
With the analysis among related 1,143 patents applied in the last 5 years. We discover 227 most active companies in this area. The fast-growing Sarepta Therapeutics, Inc., Research Institute at Nationwide Childrens Hospital, Modalis Therapeutics Corp. take 31.58% of patent filing during this period.
Sarepta Therapeutics, Inc.
Massachusetts, United States
Patent: 174
Research Institute at Nationwide Childrens Hospital
Ohio, United States
Patent: 151
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 36
Nippon Shinyaku Co., Ltd.
Kyoto-fu, Japan
Patent: 35
Tokyo-to, Japan
Patent: 28
Regents of the University of California
California, United States
Patent: 23
Noord-Holland, Netherlands
Patent: 18
Pliant Therapeutics, Inc.
California, United States
Patent: 18
Tokyo-to, Japan
Patent: 17
National Center of Neurology & Psychiatry
Tokyo-to, Japan
Patent: 16
With the analysis among related 1,143 patents in last 5 years, we discover 127 new entrants. Modalis Therapeutics Corp., Astellas Pharma, Inc., Pliant Therapeutics, Inc. are the most active new entrants in this area.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 36
Tokyo-to, Japan
Patent: 28
Pliant Therapeutics, Inc.
California, United States
Patent: 18
Tokyo-to, Japan
Patent: 17
Astria Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Avidity Biosciences, Inc.
California, United States
Patent: 13
Antisense Therapeutics Ltd.
Victoria, Australia
Patent: 12
Massachusetts, United States
Patent: 11
Bretagne, France
Patent: 10
Rutgers State University of New Jersey
New Mexico, United States
Patent: 9
With the analysis among 1,116 patents, we discovered top 112 universities and scientific research institutions by total patent application. The University of Nevada, Reno, Université Laval, Brown University are dominant in this area. They take 26.61% of the total patent filing.
The University of Nevada, Reno
Nevada, United States
Patent: 33
Rhode Island, United States
Patent: 27
The University of Chicago
Illinois, United States
Patent: 25
Washington, United States
Patent: 19
North Carolina, United States
Patent: 17
The University of Western Australia
Tasmania, Australia
Patent: 17
The Johns Hopkins University
Minnesota, United States
Patent: 14
Consejo Superior de Investigaciones Científicas